help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 3, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0072
A more recent version of this article appeared on October 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
17/10/2028    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, M. M.
Right arrow Articles by Carlberg, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, M. M.
Right arrow Articles by Carlberg, C.

Submitted on March 4, 2003
Accepted on June 26, 2003

Corepressor excess shifts the two side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor

Manuel Macias Gonzalez1, Petra Samenfeld1, Mikael Peräkylä1, and Carsten Carlberg1*

1 Departments of Biochemistryand Chemistry, University of Kuopio, FIN-70211 Kuopio, Finland

* To whom correspondence should be addressed. E-mail: carlberg{at}messi.uku.fi.

The vitamin D receptor (VDR) is an endocrine nuclear receptor (NR) that binds with high affinity its natural ligand 1{alpha},25-dihydroxyvitamin D3 (1{alpha}, 25(OH)2D3). Gemini is a 1{alpha},25(OH)2D3 analog with two identical side chains that despite its significantly increased volume binds to the VDR and can function as a potent agonist. This study demonstrates that at excess corepressor (CoR) levels Gemini shifts from an agonist to an inverse agonist that actively recruits CoR proteins to the VDR and mediates super-repression. Under these conditions Gemini stabilizes the VDR into a silent conformation, in which helix 12 of the ligand-binding domain is repositioned and thus unable to contribute to coactivator (CoA) interaction. Amino acid F422 has been described as the lock of helix 12 and seems to be the most critical VDR residue in the inverse agonistic action of Gemini. Molecular dynamics simulations of the Gemini-VDR complex support these observation by indicating that the second side chain of Gemini induces tension to the receptor structure that can be released by a shift of helix 12. Taken together, Gemini is the first described (conditional) inverse agonist to an endocrine NR and may function as a sensor for the cell-specific CoA/CoR ratio.


Key words: gene regulation • nuclear receptors • vitamin D receptor • corepressor • inverse agonist • receptor conformations • molecular dynamics simulation

NURSA Molecule Pages Link:

Nuclear Receptors:   VDR
Coregulators:   NCOR
Ligands:   Calcitriol



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Molnar, M. Perakyla, and C. Carlberg
Vitamin D Receptor Agonists Specifically Modulate the Volume of the Ligand-binding Pocket
J. Biol. Chem., April 14, 2006; 281(15): 10516 - 10526.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Lempiainen, F. Molnar, M. Macias Gonzalez, M. Perakyla, and C. Carlberg
Antagonist- and Inverse Agonist-Driven Interactions of the Vitamin D Receptor and the Constitutive Androstane Receptor with Corepressor Protein
Mol. Endocrinol., September 1, 2005; 19(9): 2258 - 2272.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Perakyla, M. Malinen, K.-H. Herzig, and C. Carlberg
Gene Regulatory Potential of Nonsteroidal Vitamin D Receptor Ligands
Mol. Endocrinol., August 1, 2005; 19(8): 2060 - 2073.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Molnar, M. Matilainen, and C. Carlberg
Structural Determinants of the Agonist-independent Association of Human Peroxisome Proliferator-activated Receptors with Coactivators
J. Biol. Chem., July 15, 2005; 280(28): 26543 - 26556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society